Genetic Variants in SRD5A2 in a Spectrum of DSD Patients from Australian Clinics Highlight Importance of Genetic Testing alongside Typical First-Line Investigations
Sexual Development · 2023
DOI: 10.1159/000527754 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sexual Development, 2023. Verfasst von Gorjana Robevska und 11 weiteren Autor:innen. Beteiligte Einrichtung: Murdoch Children's Research Institute, Melbourne, Victoria, Australia. Hauptthemen laut MEDLINE: Genetic Testing, Disorder of Sex Development, 46,XY. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
Steroid 5-alpha reductase deficiency (5α-R2D) is a rare condition caused by genetic variants that reduce the activity of the enzyme that converts testosterone into dihydrotestosterone. The clinical spectrum of 5α-R2D is known to overlap with other 46,XY differences of sex development (DSD) such as androgen insensitivity or gonadal dysgenesis. However, the clinical trajectories of the aetiologies can differ, with 5α-R2D presenting its own challenges.
Methods
In this study, we have collated clinical information for five individuals with variants in SRD5A2 identified using research genetic testing in an Australian paediatric setting.
Results
We describe how a genetic finding resolved or confirmed a diagnosis for these individuals and how it guided clinical management and family counselling.
Conclusion
This work highlights the importance of early genetic testing in children born with 46,XY DSD where it complements traditional first-line testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Royal Children's Hospital Melbourne, Melbourne, Victoria, Australia.
- Department of Paediatric Endocrinology and Diabetes, Monash Children's Hospital, Clayton, Victoria, Australia.
- Department of Diabetes and Endocrinology, Women's and Children's Hospital, Adelaide, South Australia, Australia.
- Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia.
- Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
Zitieren
APA
Robevska, G., Hanna, C., van den Bergen, J., Welch, J., Couper, J., Harris, S., Joshi, K., Brown, J., Sabin, M., Sinclair, A., O'Connell, M., & Ayers, K. (2023). Genetic Variants in SRD5A2 in a Spectrum of DSD Patients from Australian Clinics Highlight Importance of Genetic Testing alongside Typical First-Line Investigations. Sexual Development. https://doi.org/10.1159/000527754
Vancouver
Robevska G, Hanna C, van den Bergen J, Welch J, Couper J, Harris S, et al. Genetic Variants in SRD5A2 in a Spectrum of DSD Patients from Australian Clinics Highlight Importance of Genetic Testing alongside Typical First-Line Investigations. Sexual Development. 2023. doi:10.1159/000527754
BibTeX
@article{Robevska2023,
author = {Robevska, Gorjana and Hanna, Chloe and van den Bergen, Jocelyn and Welch, John and Couper, Jennifer and Harris, Shannon and Joshi, Kriti and Brown, Justin and Sabin, Matthew and Sinclair, Andrew and O'Connell, Michele and Ayers, Katie},
title = {Genetic Variants in SRD5A2 in a Spectrum of DSD Patients from Australian Clinics Highlight Importance of Genetic Testing alongside Typical First-Line Investigations},
journal = {Sexual Development},
year = {2023},
doi = {10.1159/000527754}
}
EUVIMED